You are here

  • Home
  • Archive
  • Volume 30, Issue 11
  • Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010)

Article info

Article menu
Download PDFPDF
Clinical trial
Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010)

Authors

  1. Correspondence to Dr Jihong Liu, Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; liujih{at}mail.sysu.edu.cn
View Full Text

Citation

Tu H, Huang H, Xian B on behalf of the PHENIX Investigators and the CSEM group, et al
Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010)
International Journal of Gynecologic Cancer 2020;30:1829-1833.

Publication history

  • Accepted August 10, 2020
  • First published September 24, 2020.
Online issue publication 
January 08, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.